Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO to Enhance Hematopoietic Stem Cell Engraftment After Transplantation
ChiCTR-OIN-17010831Phase 2Recruiting
- Sponsor
- Hengxiang Wang
- Start
- Apr 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of recombinant human thrombopoietin in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), aplastic anemia and 1 more (2 arms), sponsored by Hengxiang Wang. Primary endpoints: neutrophil engraftment, platelet engraftment and 1 more. Started Apr 2014; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)aplastic anemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on ChiCTR-OIN-17010831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17010831.